Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rossari BiotechNSE:ROSSARI -0.44%84 Return-on-Tangible-Asset is 6.80% as of Jun. 2026, which is 46% below its 10-year median of 12.65. GuruFocus rates NSE:ROSSARI with a GF Score™ of 84/100 and a GF Value™ of ₹967.87 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,612 Chemicals companies, Rossari Biotech ranks better than 80.83% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Rossari Biotech's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹1,404 Mil. Rossari Biotech's average total tangible assets for the quarter that ended in Jun. 2026 was ₹20,649 Mil. Therefore, Rossari Biotech's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 6.80%.
The historical rank and industry rank for Rossari Biotech's Return-on-Tangible-Asset or its related term are showing as below:
NSE:ROSSARI'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 8.03 Med: 12.65 Max: 22.35
Current: 8.12
During the past 9 years, Rossari Biotech's highest Return-on-Tangible-Asset was 22.35%. The lowest was 8.03%. And the median was 12.65%.
NSE:ROSSARI's Return-on-Tangible-Asset is ranked better than 80.83% of 1612
companies
in the Chemicals industry
Industry Median: 3.07
vs NSE:ROSSARI: 8.12
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Rossari Biotech Return-on-Tangible-Asset Related Terms
Rossari Biotech Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: Return-on-Tangible-Asset Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech Return-on-Tangible-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.80% mean?
Rossari Biotech (NSE:ROSSARI) has a Return-on-Tangible-Asset of 6.80% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rossari Biotech and its competitors. This is 46% below median its historical median of 12.65. Over the past decade, Rossari Biotech's Return-on-Tangible-Asset has ranged from 8.03 to 22.35. According to the industry distribution chart, Rossari Biotech ranks #309 out of 1612 companies in the Chemicals industry, placing it in the top 19.2%.
Is Rossari Biotech's Return-on-Tangible-Asset too high?
Rossari Biotech's current Return-on-Tangible-Asset of 6.80% is 46% below median its 10-year median of 12.65. Over the past 10 years, this metric has ranged from a low of 8.03 to a high of 22.35. The Chemicals industry median Return-on-Tangible-Asset is 3.07. Rossari Biotech's value of 6.80% is 121.5% above this industry median. Based on the distribution chart, Rossari Biotech ranks #309 out of 1612 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Return-on-Tangible-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #309 out of 1612 companies for Return-on-Tangible-Asset. This places Rossari Biotech in the top 19% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 3.07. Rossari Biotech's value of 6.80% is 121.5% above this benchmark. Historically, Rossari Biotech's own Return-on-Tangible-Asset has ranged from 8.03 to 22.35 over the past decade. While the company's 10-year median is 12.65 vs. the industry median of 3.07, Rossari Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Chemicals company?
The median Return-on-Tangible-Asset among Chemicals companies is 3.07, based on 1,612 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current Return-on-Tangible-Asset of 6.80% is 121.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median Return-on-Tangible-Asset is 3.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current Return-on-Tangible-Asset is 6.80%, which is 46% below median its own 10-year median of 12.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹967.87, compared to a current price of ₹489.80 — trading 49.4% below its estimated fair value. The current Return-on-Tangible-Asset is 6.80%, which is 46% below median its 10-year median of 12.65 and 121.5% above the Chemicals industry median of 3.07. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Return-on-Tangible-Asset is 6.80% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹489.80 is trading 49.4% below its estimated GF Value™ of ₹967.87.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
Return-on-Tangible-Asset: 6.80% (46% below median its 10-year median of 12.65)
GF Value™: ₹967.87 vs. price of ₹489.80 (49.4% below fair value)
Industry Position: 121.5% above the Chemicals median (#309 of 1612)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score
Get the complete analysis for NSE:ROSSARI
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
